Articles by Christian H. Martini in JoVE
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver Eleonora M. de Leede1, Mark C. Burgmans2, Christian H. Martini3, Fred G. J. Tijl4, Arian R. van Erkel2, Jaap Vuyk3, Ellen Kapiteijn5, Cornelis Verhoef6, Cornelis J. H. van de Velde1, Alexander L. Vahrmeijer1 1Department of Surgery, Leiden University Medical Centre, 2Department of Radiology, Leiden University Medical Centre, 3Department of Anesthesiology, Leiden University Medical Centre, 4Department of Extracorporeal Circulation, Leiden University Medical Centre, 5Department of Medical Oncology, Leiden University Medical Centre, 6Department of Surgery, Erasmus MC Cancer Institute In this manuscript, we describe percutaneous isolated hepatic perfusion with simultaneous chemofiltration as treatment for unresectable liver metastases. This procedure is performed under general anaesthesia in the angiosuite by an experienced team, consisting of an interventional radiologist, a clinical perfusionist and anaesthesiologist.
Other articles by Christian H. Martini on PubMed
Effect of Variations in Depth of Neuromuscular Blockade on Rating of Surgical Conditions by Surgeon and Anesthesiologist in Patients Undergoing Laparoscopic Renal or Prostatic Surgery (BLISS Trial): Study Protocol for a Randomized Controlled Trial Trials. 2013 | Pubmed ID: 23452344 Surgical conditions in laparoscopic surgery are largely determined by the depth of neuromuscular relaxation. Especially in procedures that are confined to a narrow working field, such as retroperitoneal laparoscopic surgery, deep neuromuscular relaxation may be beneficial. Until recently, though, deep neuromuscular block (NMB) came at the expense of a variety of issues that conflicted with its use. However, with the introduction of sugammadex, rapid reversal of a deep NMB is feasible. In the current protocol, the association between the depth of NMB and rating of surgical conditions by the surgeon and anesthesiologist is studied.
Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies Cardiovascular and Interventional Radiology. Dec, 2015 | Pubmed ID: 26718962 Liver malignancies are a major burden of disease worldwide. The long-term prognosis for patients with unresectable tumors remains poor, despite advances in systemic chemotherapy, targeted agents, and minimally invasive therapies such as ablation, chemoembolization, and radioembolization. Thus, the demand for new and better treatments for malignant liver tumors remains high. Surgical isolated hepatic perfusion (IHP) has been shown to be effective in patients with various hepatic malignancies, but is complex, associated with high complication rates and not repeatable. Percutaneous isolated liver perfusion (PHP) is a novel minimally invasive, repeatable, and safer alternative to IHP. PHP is rapidly gaining interest and the number of procedures performed in Europe now exceeds 200. This review discusses the indications, technique and patient management of PHP and provides an overview of the available data.